Recent Articles from Business Wire

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced it received the 2026 Prix Galien USA Award for Best Medical Technology for Shield™, the leading blood test for colorectal cancer (CRC) detection and first to receive FDA approval for primary CRC screening, for its achievements in expanding patient choice and increasing screening participation for CRC.

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in the following upcoming investor conferences:

Moleculent AB, the life sciences technology company pioneering functional profiling, today announced Glimt, an automated platform that detects cell-cell interactions directly in formalin-fixed, paraffin-embedded (FFPE) tissue. The Glimt platform is now available to selected academic and biopharma labs through the Moleculent early access program, with commercial shipments expected in 2027.

Keel Holdings, LLC ("Keel"), an advanced manufacturing leader for the U.S. Navy and broader defense applications for naval, land and space, recently hosted the grand opening of the company’s new Prep & Paint Facility at its Yonges Island, South Carolina shipyard.

Infravision today announced the deployment of its drone stringing technology on Entergy’s Amite South Reliability Project in Louisiana. Working alongside Utility Lines Construction Services (ULCS), Infravision is helping install pulling lines across challenging terrain while freeing up construction crews and equipment for other work.

Accelsius, a leader in two-phase, direct-to-chip liquid cooling for AI and high-performance computing, today announces its participation in the National Science Foundation (NSF) Center for Energy-Smart Electronic Systems (ES2), a federal data center energy efficiency research program.

XTEND AI Robotics, Inc. (NYSE: XTND) (“XTEND” or the “Company”), a leader in software systems and Physical AI, today announced that its Asia-Pacific subsidiary, Performance Rotors Pte Ltd, successfully completed delivery under a defense contract valued at approximately $2.8 million with a customer in the region. Deliveries were completed in September 2026. The contract is included in the previously provided preliminary, unaudited revenue range of approximately $24.5 to $26.5 million through September 30, 2026.

Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced the successful deployment of its PowerTrack™ Platform at Border Basin Solar, a 152 MWdc (120 MWac) utility-scale solar project, owned and developed by Energix US, LLC. Border Basin is now operational and delivering clean energy into the PJM Interconnection market.

Jupiter Endovascular, Inc. announced new analyses from its SPIRARE II pivotal trial showing that restoring normal pulmonary artery pressure with the Vertex™ Thrombectomy System tracked with right heart recovery at 48 hours. The analysis also demonstrated that reaching the lower lobes of the lungs with the system was associated with greater hemodynamic restoration. The data was presented at the Transcatheter Cardiovascular Therapeutics (TCT 2026) conference in San Diego by Sripal Bangalore, MD, MHA, Professor of Medicine at NYU Grossman School of Medicine.

Energy Capital Partners (“ECP”) today announced the completion of its acquisition of an 892-megawatt (“MW”) portfolio of natural gas-fired cogeneration assets located in Texas and Illinois (the “Portfolio”) from Fengate Asset Management (“Fengate”).

Honeywell Technologies (NASDAQ: HON) today announced its participation at the 2026 RBC Capital Markets Global Industrials Conference in New York City. On Tuesday, November 17, 2026, at 8:00 a.m. EST, Vimal Kapur, Chairman and Chief Executive Officer, will join the keynote session, moderated by CNBC’s Brian Sullivan, co-anchor of “Power Lunch” and Senior National Correspondent. A real-time webcast of the keynote address can be accessed at investor.honeywell.com, where related materials will be posted following the presentation and a replay of the webcast will be available for 30 days following the presentation.

Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company specializing in satellite technology, space transportation, and in-orbit services, today announced that OQ Technology has selected Momentus to fly its 5G Narrowband Internet of Things (NB-IoT) payload on the Company’s Vigoride-9 mission, scheduled for launch in Q4 2027.

Canopy, the all-in-one practice management software designed to help accountants build an autonomous firm, today announced general availability of Tax Workflow Automation, an AI-powered suite that takes tax work from the first document request to the signed, paid return in one connected workflow. With new task-template automations, firms can now send every client a personalized questionnaire and document checklist in bulk, ending the long-standing tradeoff between scale and a personal client experience.

 Cotality, a leader in property information, analytics, and data-enabled solutions, today released its Home Price Index™ with September 2026 data. National single-family home price growth continues to rise nationally in September 2026, rising 1.7% year-over-year but falling 0.3% from August, with the national median above $400,000.

Fastly, Inc. (NASDAQ: FSLY), a leader in global edge cloud platforms, today announced that its management team will be participating at upcoming investor conferences. Details for each event are as follows:

PagerDuty, Inc. (NYSE: PD), the global leader in AI-first incident management, today announced Paige, a next generation SRE agent built to work as a member of operations, engineering, and DevOps teams to detect, investigate, and remediate issues across increasingly complex systems. Paige orchestrates incident resolution on the PD Reliability Platform, PagerDuty's flagship product (previously known as PagerDuty Operations Cloud). The PD Reliability Platform unifies signal intelligence, incident management, and automation for blended teams of agents and humans to automate detection, investigation, and remediation combined with the operational context and telemetry needed to act. Additionally, PagerDuty has established PD Labs, a new AI innovation center built in the open with design partners.

Strand Therapeutics, a clinical-stage biotechnology company pioneering programmable mRNA therapeutics, today announced two presentations at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting, taking place November 4-8 in Phoenix: an oral presentation featuring updated clinical data from its STX-001 program and a trial-in-progress poster on the design of ASCENT-1, the company’s Phase I trial of its flagship clinical program STX-003.

BGC Group, Inc. (Nasdaq: BGC) (“BGC” or the “Company”), a leading global marketplace, data, and financial technology services company, today announced that JP Aubin will become Vice Chairman of BGC and will step down as Co-Chief Executive Officer, effective at the close of business on December 31, 2026. John Abularrage and Sean Windeatt will continue to lead BGC as Co-Chief Executive Officers, overseeing all of the Company’s regions and businesses. As Vice Chairman, Mr. Aubin will report to the Co-CEOs and continue to support BGC’s growth and innovation.

Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Jennifer F. Tseng, MD, MPH, a nationally recognized surgical oncologist, to its Scientific Advisory Board. Dr. Tseng will advise Eureka on the clinical development of its ARTEMIS® CAR-T programs for solid tumors, with a focus on indication strategy and clinical trial design.

Solius Labs, the world’s only Personalized Sunlight company, today announced that a growing network of longevity clinics and premier, medically driven health clubs, including Extension Health, WellWay, Monarch Athletic Club, and Humanaut Health, now offer Solius, the only personalized UVB light therapy that is FDA-cleared, clinically proven, and available without a prescription. Nutrition, exercise, and sleep get daily attention. The fourth pillar of health, sunlight, is what most people are missing as modern life keeps us indoors, especially heading into the winter months.

Operation HOPE, a national nonprofit dedicated to helping low- and moderate-income Americans thrive in an ever-changing economy, today announced that “Juanita,” its AI-powered financial wellness coach, is now accessible through the organization's HOPE in Hand mobile app, available for download on Apple and Android devices. The integration expands access to Juanita's personalized financial guidance, making it easier for individuals to get support and information to help them navigate financial decisions and work toward their financial goals.

Solovis®, a leading multi-asset-class portfolio management and analytics platform for institutional investors, today opened a public preview of Solovis IO, intelligence for the whole investment office. Jon Fernandez, former Chief Operating Officer of Yale Investments, has joined the Solovis Board of Directors and has been working with Solovis to bring the voice of the client and the market to the Solovis IO roadmap. Ryan Manougian has joined Solovis as Senior Vice President of Sales.

C.J. Lawrence® (“CJL”), a division of Apollon Wealth Management, LLC, today announced the launch of the Buffered Bulldog ETF (ACJL), an exchange-traded fund that brings CJL’s “Bulldog” equity strategy to the ETF market, complemented by an options overlay on the S&P 500.

TENICA Global Solutions (“TENICA” or “the Company”), a leading provider of integrated engineering, mission operations, cybersecurity, and digital modernization solutions supporting critical space, intelligence, and defense missions, today announced that it has acquired Trinity Enterprise Services, LLC (“Trinity”), a provider of full-lifecycle systems engineering and integration solutions to the U.S. Intelligence Community. The acquisition strengthens TENICA's presence at key agencies across the Intelligence Community and expands its technical capabilities as it continues to build a differentiated national security platform. Financial terms of the transaction were not disclosed.

The majority of online survey participants are uncomfortable with the idea of an AI-generated digital twin being created from their data, according to a new study from Prolific. As the research industry increasingly explores these AI tools that enable faster and cheaper data collection, these findings point to an important but often overlooked factor: the attitudes of the participants, who stand to lose income, influence and standing if human survey research is left behind.

Corridian, a New England defense technology company building ultra-large Autonomous Underwater Vehicles (AUVs), today debuted with a $38 million seed round led by Point72 Ventures, with participation from Balerion Space Ventures, Harpoon Ventures, DCVC, Marlinspike, and a syndicate of additional defense and deep-tech investors. The funding will support continued development of the company’s flagship AUV platform, buildout of its research and development facility, and active hiring for its rapidly expanding undersea engineering team.

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced that Chief Executive Officer Ian F. Smith and Chief Patient Officer Jason Hoitt will present at the following upcoming investor conferences:

Today, CoLab unveiled engineering review, a multi-release expansion of the mechanical CAD review experience it’s known for to bills of materials, simulation, ECAD, and a growing range of other engineering data. BOM review ships first in November 2026, followed by simulation and ECAD review in 2027.

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, today announced that management will participate in the following investor conferences:

Hightower Advisors today announced that Altium Wealth (“Altium”), an established Hightower practice with more than $9 billion in assets under management*, will join Hightower Signature Wealth (“HTSW”) and extend its investment capabilities across the Hightower One platform.

Teamily AI, a human–agent collaboration platform that enables people and AI agents to work together in a unified, context-aware workspace, today announced significant growth and commercial milestones following a quarter of rapid global expansion. The company grew from 10,000 to 320,000 sign-ups in a single quarter, a 32× increase that works out to a compound monthly growth rate of 217.5%, just three months after its public launch in July 2026. With positive gross margins on paying users, and growing adoption among professional teams and businesses, Teamily AI establishes a foundation for scalable product-led growth (PLG).

Lyra Health, the leading provider of workforce mental health benefits, today released its 2027 Workforce Mental Health Trends Forecast. The report finds that 92% of benefits leaders say mental health is essential to sustaining business performance, with 83% agreeing that this has become more important over the last three years. This comes as organizations confront new workforce challenges, including AI and the evolving role of managers, increasingly complex mental health needs, and growing demand for whole-family support.

Stellar Cyber, an open and agentic Integrated Security Operations Center (ISOC) platform company, today announced that CTO and founder Aimei Wei has been named a winner in the 2026 Herizon Awards, in the category of Founder/Visionary. Presented by the Business Intelligence Group (BIG), the award recognizes women who are changing how the world works.

DNSFilter, the DNS-first security company, powered by AI, today released The Cost of Shadow AI, part of its 2026 Visibility Deficit cybersecurity survey series, revealing that while organizations are moving new security budget into AI governance, many cannot see the AI tools connecting to their systems. One in five (20.1%) say an unapproved AI connection has already led to a security incident. The study found that this visibility gap runs through how AI tools are approved, whether existing controls are working, and what is actually running on corporate networks.

BostonGene, developer of an AI model for tumor and immune biology, today announced that it has been awarded three Gold Stevie® Awards in the 2026 Stevie® Awards for Technology Excellence, taking top honors as Company of the Year, New Product of the Year, and Technology Breakthrough of the Year in Biotechnology.

Fort George Belize, Autograph Collection, part of Marriott Bonvoy’s distinctive portfolio of independent hotels, announces its debut as a landmark waterfront retreat in the historic Fort George neighborhood. Celebrated for its individual character and story, the hotel enters a new chapter that honors its longstanding connection to Belize City while inviting travelers to experience the destination’s history, culture, and Caribbean spirit through a refreshed and distinctly local hospitality experience.

Equity Medical, LLC (“Equity Medical”), a physician-owned, integrated national site network conducting high-performance Phase IA–IV clinical research, today announced it has completed the acquisition of a majority stake in Skylight Health Research, Inc. (“Skylight”), a clinical research site network with locations in Burlington, Massachusetts and Colorado Springs, Colorado. Terms of the transaction were not disclosed.

Arcadian Risk Capital (“Arcadian”), the Bermuda-headquartered managing general agent (MGA), today announced the appointment of Michael Saitta as Global Head of Tax and Representations & Warranties (“TRW”) Insurance, based in New York. Michael will lead the strategic expansion, underwriting operations and portfolio management of Arcadian’s global TRW business.

Sycamore Labs, Inc. announced the general availability of their AI platform that enables organizations to build custom, enterprise-grade agentic software using the expertise of the people who know their businesses best. With Sycamore Build, employees can transform complex business processes into working agents and applications, without needing to know how to code.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the third quarter ended September 30, 2026 after the markets close on Monday, November 9, 2026. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day.

PHINIA Inc. (NYSE: PHIN), a diversified industrial supplier and global leader in the development of fuel systems, electrical systems and aftermarket solutions, announced today that it will participate in the Stephens Annual Investment Conference on Tuesday, November 17, 2026. Conference participation will be in-person and include a Q&A session to discuss dynamics across the various markets PHINIA serves around the world and the Company’s business.

The Marzetti Company (Nasdaq: MZTI) reported results today for the company’s fiscal first quarter ended September 30, 2026.

SpaceCorp, a closed-end investment fund focusing on the space economy and advised by FutureCorp Asset Management LLC, today announced that it has publicly filed a Form N-2 registration statement with the U.S. Securities and Exchange Commission for the proposed initial public offering of its shares of common stock. The number of shares of common stock to be offered and the size of the fund have not yet been determined.

QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced a five-year colocation agreement for a contracted 0.5 MW of data center capacity in Columbia, South Carolina, the company’s first site in the state. QumulusAI expects service to begin Dec. 21, 2026.

Sunoco LP (TXSE: SUN) (“SUN” or the “Partnership”) and SunocoCorp LLC (TXSE: SUNC) ("SUNC") today reported financial and operating results for the quarter ended September 30, 2026.

Cross Country Healthcare today announced the appointments of Susana E. Pichardo as Chief Financial Officer and Andrew Harris as Chief Transformation Officer, both reporting to Chief Executive Officer Joel Tremblay. The appointments strengthen the executive leadership team as the company invests in financial leadership and enterprise transformation to advance its growth strategy.

Energy Transfer LP (TXSE:ET) (“Energy Transfer” or the “Partnership”) today reported financial results for the quarter ended September 30, 2026.

Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced financial results for the quarter ended September 30, 2026, and highlighted recent corporate accomplishments and 2026 milestones.

Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, today announced the launch of Muni Sweep, a session-based trading protocol for the municipal bond market.

The Real Brokerage Inc., a leading technology-enabled real estate platform redefining the industry through innovation and agent culture, today announced that Cody Burger and Dennis Buchheit are bringing their 30-agent real estate brokerage, previously operating as Unlimited, to the company under the name The Team.

Progentos Therapeutics, a biotechnology company developing regenerative medicines for multiple sclerosis (MS) and other demyelinating diseases, today announced that the first participant has been dosed in its Phase 1/2a clinical trial of PRO-1562 (NCT07826689). PRO-1562 is a novel oral small molecule designed to regenerate myelin in patients with demyelinating diseases, like MS, with the potential to protect neuroaxonal integrity and restore neurologic function.

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following conferences:

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) (“NCDL” or the “Company”), a business development company externally managed by its investment adviser, Churchill DLC Advisor LLC (the “Adviser”), and by its sub-adviser, Churchill Asset Management LLC (“Churchill”), today reported financial results for the third quarter ended September 30, 2026.

Solen Software Group, a permanent capital partner to mission-critical software companies, today announced an investment partnership with Teletask Inc., the two-way messaging platform that WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) and public health agencies use to reach families by text, voice, and email. Teletask supports public health agencies in more than 35 states, including WIC agencies serving over three million participants, and delivers more than 100 million messages a year.

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or otherwise acquired Gildan Activewear Inc. (NYSE: GIL) securities between February 19, 2025 and June 15, 2026, inclusive (the “Class Period”). Gildan describes itself as "a leading vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and hosiery products."

CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the publication of a new analysis from the Kidney Allograft Outcomes AlloSure Registry (KOAR), a landmark multicenter study, in the journal Transplantation.

Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at the annual Transcatheter Cardiovascular Therapeutics Conference (TCT 2026). The ELUCIDATE study, which supported Elucid’s recent U.S. Food and Drug Administration (FDA) 510(k) clearance of the FFR-IQTM software, demonstrated 92.9 percent vessel-level diagnostic accuracy for Elucid’s FFR-IQ technology versus invasive fractional flow reserve (FFR). ELUCIDATE also demonstrated high accuracy in the “gray zone,” FFR values between 0.75 and 0.85, which represent a physiological area of uncertainty when evaluating moderate stenosis.

Everforth™ ECS®, a trusted mission operations partner for defense, intelligence, and federal civilian agencies, and the Federal Government Segment of Everforth, Inc. (NYSE: EFOR), today announced it has secured an up to two-year prime contract extension with the National Geospatial-Intelligence Agency (NGA). The extension has a potential value of more than $200 million.

Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended September 30, 2026. To view the detailed third quarter 2026 earnings press release and presentation, please visit the company’s investor relations website at https://investor.alkermes.com.

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today published its monthly origination volume for October 2026 along with the latest Upstart Macro Index (UMI) reading. For historical data and more information, see upstart.com/volume and upstart.com/umi.

Sophia Learning, an online, on-demand, self-paced learning platform offering courses recommended for college-level credit by ACE®, today announced a new partnership with Rocky Mountain College of Art + Design (RMCAD). Through this partnership, RMCAD, a Denver-area college focused on art and design education, joins Sophia Learning’s growing network of partner colleges and universities, providing eligible students with a flexible pathway to complete select general education coursework.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the third quarter ended September 30, 2026, and provided a business update.

Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences:

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its Signatera molecular residual disease (MRD) test has received Medicare coverage through the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostics Services Program (MolDX) in hepatocellular carcinoma (HCC). The coverage includes serial Signatera testing in the surveillance setting for patients with early-stage HCC who have no post-surgical evidence of disease.

Yum! Brands, Inc. (NYSE: YUM) today reported results for the third quarter ended September 30, 2026. Third-quarter GAAP EPS was $5.92 and third-quarter EPS excluding Special Items was $1.56.

Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) today announced the Audit Committee of the Company’s Board of Directors, after consultation with the Company’s management, concluded there were material errors in the Company’s previously issued consolidated financial statements for fiscal years ended December 27, 2025, December 28, 2024, and December 30, 2023 contained in the Company’s Annual Report on Form 10-K for the fiscal year 2025, and in its previously issued unaudited condensed consolidated financial statements for each of the quarterly and year-to-date periods within fiscal years 2025 and 2024 as well as the quarterly and year-to-date periods ended June 27, 2026 and March 28, 2026.

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today announced financial results for the quarter ended September 30, 2026. Upstart will host a conference call and webcast at 5:00 a.m. Pacific Time today. An earnings presentation and link to the webcast are available at ir.upstart.com.

Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its third quarter ended September 27, 2026.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2026.

Knife River Corporation (NYSE: KNF), an aggregates-based, vertically integrated construction materials and contracting services company, today announced financial results for the third quarter ended September 30, 2026.

Versant Media Group, Inc. (Nasdaq: VSNT) (the “Company”) today reported operating and financial results for the third quarter of 2026, highlighted by strong performance across its businesses, including favorable network audience trends, double-digit Platforms revenue growth and significant cash flow generation.

UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today reported results for the third quarter ended September 30, 2026.

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 2026 Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 10:30 a.m. (GMT).

Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) (the “Company,” “we,” and “our”), a leading real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market, today reported financial results for the quarter ended September 30, 2026.

Entegris, Inc. (Nasdaq: ENTG), a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries, today announced two important milestones in its strategic expansion into the market for silicon carbide (SiC) and diamond-enabled thermal management materials solutions for next-generation AI advanced packaging.